Your browser doesn't support javascript.
loading
A recurrent MORC2 mutation causes Charcot-Marie-Tooth disease type 2Z.
Vujovic, Dragan; Cornblath, David R; Scherer, Steven S.
Affiliation
  • Vujovic D; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Cornblath DR; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Scherer SS; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Peripher Nerv Syst ; 26(2): 184-186, 2021 06.
Article in En | MEDLINE | ID: mdl-33844363
ABSTRACT
We found a p.Ala406Val (c.1217C > T) mutation in MORC2 in three individuals, from two families. All three individuals were evaluated and clinical electrophysiology was completed. The neuropathy began in childhood to early adulthood, with distal weakness progressing to proximal weakness. Vinblastine (for Hodgkin lymphoma) acutely worsened the weakness in one patient. This finding confirms that that the p.Ala406Val mutation in MORC2 causes severe neuropathy. In addition, we report the first case of vinblastine neurotoxicity in Charcot-Marie-Tooth disease type 2Z.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Charcot-Marie-Tooth Disease Type of study: Etiology_studies Limits: Humans Language: En Journal: J Peripher Nerv Syst Journal subject: NEUROLOGIA Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Charcot-Marie-Tooth Disease Type of study: Etiology_studies Limits: Humans Language: En Journal: J Peripher Nerv Syst Journal subject: NEUROLOGIA Year: 2021 Type: Article Affiliation country: United States